Nkarta, Inc(NASDAQ:NKTX) 
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific p...
Website: http://www.nkartatx.com
Founded: 2015
CEO: Paul J. Hastings
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.63
H 1.69
L 1.59
C 1.63
V 1,154,569
10EMA 1.63
20EMA 1.63
60EMA 1.63
120EMA 1.63
250EMA 1.63